Guanfacine Tablet, Extended Release
Product Images NDC 70436-042

9 FDA label images from Slate Run Pharmaceuticals, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Guanfacine (NDC 70436-042). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Slate Run Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of guanfacine hydrochloride showing a dichlorophenyl group attached to an acetamide moiety linked to a guanidine group.*
FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
A pharmacokinetic plasma concentration-time graph comparing Guanfacine Extended-Release 1 mg QD with Immediate-Release Guanfacine 1 mg QD over 24 hours. The y-axis shows guanfacine plasma concentration in ng/mL, and the x-axis shows time in hours. Extended-release maintains steadier plasma levels; immediate-release shows a rapid peak followed by decline.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
A pharmacokinetic (PK) chart showing fold changes and 90% confidence intervals for Cmax and AUC due to various CYP3A4/5 inhibitors and inducers, as well as oral methylphenidate and lisdexamfetamine dimesylate. The chart compares relative changes with reference values on the x-axis, ranging from 0 to 5.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
A forest plot chart showing the fold change and 90% confidence intervals for pharmacokinetic parameters (Cmax and AUC) of oral methylphenidate and lisdexamfetamine dimesylate compared to a reference. The x-axis represents the change relative to the reference, ranging from 0.0 to 2.0.*
FDA Label Image

Figure-4 (Figure 4)

Figure-4 (Figure 4)
A Kaplan-Meier survival curve comparing time to treatment failure over days between placebo and SPD503 groups. The x-axis represents time to treatment failure (days) and the y-axis shows the treatment failure percentage. The solid line indicates placebo, and the dashed line represents SPD503, showing differences in treatment failure rates over time.*
FDA Label Image

1mg-100ct-slaterun (1mg 100ct Slaterun Spain)

1mg-100ct-slaterun (1mg 100ct Slaterun Spain)
Label for Guanfacine Extended-Release Tablets, USP 1 mg, oral tablet dosage form. The label shows the product name, strength (1 mg), quantity (100 tablets), and manufacturer Slate Run Pharmaceuticals, LLC. It includes storage instructions and a barcode. The label indicates the tablets should not be crushed, chewed, or broken before swallowing.*
FDA Label Image

2mg-100ct-slaterun (2mg 100ct Slaterun Spain)

2mg-100ct-slaterun (2mg 100ct Slaterun Spain)
Label for Guanfacine Extended-Release Tablets, USP 2 mg, oral extended-release tablets supplied by Slate Run Pharmaceuticals, LLC. The package contains 100 tablets. Storage instructions, dosage information referencing the package insert, and safety warnings are included. Distributed from Columbus, Ohio, product of Spain.*
FDA Label Image

3mg-100ct-slaterun (3mg 100ct Slaterun Spain)

3mg-100ct-slaterun (3mg 100ct Slaterun Spain)
Label for Guanfacine Extended-Release Tablets, USP 3 mg oral tablets by Slate Run Pharmaceuticals, LLC. The label includes storage instructions, batch details, and states the package contains 100 tablets. It also advises tablets should not be crushed, chewed, or broken before swallowing.*
FDA Label Image

4mg-100ct-slaterun (4mg 100ct Slaterun Spain)

4mg-100ct-slaterun (4mg 100ct Slaterun Spain)
Label for Guanfacine Extended-Release Tablets, USP, 4 mg, oral extended-release tablets. The label shows the NDC 70436-042-01 and indicates the product is manufactured by Slate Run Pharmaceuticals, LLC. The package contains 100 tablets. Storage instructions and a barcode are also visible on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.